Scroll To Top

Med Monitor

Med Monitor


The Food and Drug Administration has granted traditional approval to Gilead Sciences' Viread and Truvada. Viread had been approved through an accelerated review in October 2001; Truvada, in August 2004. The traditional approval was based on long-term clinical trial data. ''''''''''''''' While treatment interruptions can sometimes help reduce drug-resistant HIV through a resurgence of 'wild-type' virus, HIVers resistant to Epivir are better off switching to Epivir monotherapy than completely stopping all their meds, according to a study in the April 4 issue of the journal AIDS. ''''''''''''''' The anticonvulsant drug valproic acid might improve cognitive function and restore nerve cells in the brains of HIV patients experiencing dementia, according to a study reported in the March issue of the journal Neurology. ''''''''''''''' Treating oral thrush in HIV patients with the antifungal drug posaconazole produces better long-term protection against a recurrence of the condition than treatment with fluconazole, according to a study in the April 15 issue of the journal Clinical Infectious Diseases.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

Plus Editors